Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 740-746

  Abraham, Susan C ^a   Seun, Ja Park ^b   Cruz Correa, Marcia ^c   Houlihan, Patrick S ^b   Half, Elizabeth E ^b   Lynch, Patrick M ^b   Wu, Tsung Teh ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

CpG islands; Dysplasia; Familial adenomatous polyposis; Fundic gland polyp; Methylation

Indexed keywords

BISULFITE; GENOMIC DNA; PROTON PUMP INHIBITOR;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DRUG EFFECT; DYSPLASIA; EPIGENETICS; FAMILIAL POLYPOSIS; FEMALE; GASTRIC FUNDIC GLAND POLYP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOLECULAR CLONING; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYP; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH BIOPSY; STOMACH FUNDUS; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; FEMALE; GASTRIC FUNDUS; GASTRIC MUCOSA; GENES, P16; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYPS;

EID: 7244253097     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4QUNJ4F27QK7RR0G     Document Type: Article

References (42)

1. Stolte M, Sticht T, Eidt S, et al. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26:659-665.
2. Marcial MA, Villafana M, Hernandez-Denton J, et al. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88:17114713.
3. Kinoshita Y, Tojo M, Yano T, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39:161-163.
4. Sipponen P, Laxen F, Seppala K. Cystic "hamartomatous" gastric polyps: a disorder of oxyntic glands. Histopathology. 1983;7:729-737.
5. Iida M, Yao T, Itoh H, et al. Natural history of fundic gland polyposis in patients with familial adenomatosis coli/Gardner's syndrome. Gastroenterology. 1985;89:1021-1025.
6. Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphologic study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996;27:896-903.
7. Wu TT, Kornacki S, Rashid A, et al. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22:293-298.
8. Abraham SC, Nobukawa B, Giardiello FM, et al. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic APC gene alterations. Am J Pathol. 2000;157:747-754.
9. Attard TM, Giardiello FM, Argani P, et al. Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr. 2001;32:215-218.
10. Odze RD, Quinn PS, Terrault NA, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993;24:442-448.
11. Sakai N, Tatsuta M, Hirasawa R, et al. Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps. Dig Dis Sci. 1998;43:766-772.
12. Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110:615-621.
13. El-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92:1858-1860.
14. Van Vlierberghe H, De Vos M, De Cock G, et al. Fundic gland polyps: three other case reports suggesting a possible association with acid suppressing therapy. Acta Gastroenterol Belg. 1997;60:240-242.
15. Pashankar DS, Israel DM. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr. 2002;35:658-662.
16. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116:716-720.
17. Odze RD. Gastric fundic gland polyps: are they preneoplastic lesions [letter]? Gastroenterology. 1998;114:422-423.
18. Abraham SC, Nobukawa B, Giardiello FM, et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the β-catenin gene. Am J Pathol. 2001;158:1005-1010.
19. Torbenson M, Lee JY, Cruz-Correa M, et al. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002;15:718-723.
20. Toyooka M, Konishi M, Kikuchi-Yanoshita R, et al. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res. 1995;55:3165-3170.
21. Sekine S, Shibata T, Yamauchi Y, et al. β-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440:381-386.
22. Abraham SC, Park SJ, Mugartegui L, et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002;161:1735-1742.
23. Wei J, Chiriboga L, Yee H, et al. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps. Mod Pathol. 2002;15:862-869.
24. Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209-213.
25. Stolte M, Bethke B, Ruhl G, et al. Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol. 1992;30:134-138.
26. Driman DK, Wright C, Tougas G, et al. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci. 1996;41:2039-2047.
27. Ang ST, Lieberman DA, Ippoliti AF, et al. Long term omeprazole therapy in patients with Barrett's esophagus is associated with parietal cell hyperplasia [abstract]. Gastroenterology. 1994;106:A1016.
28. Cats A, Schenk BE, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol 2000;31:684-690.
29. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Nat Acad Sci U S A. 1996;93:9821-9826.
30. INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 2002;198:55-59.
31. To KF, Leung WK, Lee TL, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer. 2002;102:623-628.
32. Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847-2851.
33. Iida S, Akiyama Y, Nakajima T, et al. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer. Int J Cancer. 2000;87:654-658.
34. Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438-5442.
35. Leung WK, Yu J, Ng EK, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer. 2001;91:2294-2301.
36. Jang TJ, Kim DI, Shin YM, et al. p16(INK4a) promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int J Cancer. 2001;93:629-634.
37. Waki T, Tamura G, Tsuchiya T, et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol. 2002;161:399-403.
38. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
39. ARF. Proc Natl Acad Sci U S A 1997;94:669-673.
40. Liggett WH Jr, Sewell DA, Rocco J, et al. p16 and p16 beta are potent growth suppressors of head and neck squamous cell carcinomas in vitro. Cancer Res. 1996;56:4119-4123.
41. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96:8681-8686.
42. Toyota M, Ho C, Ahuja N, et al. Identification of differentially methylated sequence in colorectal cancer by methylated CpG island amplification. Cancer Res. 1999;59:2307-2312.